NYSE:BSX

Boston Scientific Stock Insider Trading

Healthcare > Medical - Devices

Buy BSX

*Your capital is at risk

$50.46

+1.15 (+2.33%)

At Close: Aug 10, 2026

Boston Scientific Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 86.31. In total, the insiders bought 770.98K and sold 579.2K BSX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	86.31
● Buy	770.98K shares
● Sell	579.2K shares
78% Buy Activity Weak Negative Correlation
Buy Signal High Confidence Aug 03, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 86.31. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (78% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 14, 2026 Sell	Common Stock F-InKind	O'connor Padraig Andrew EVP, Global Operations	Officer	449 Value: $33.6K
Feb 14, 2026 Buy	Restricted Stock Units M-Exempt	O'connor Padraig Andrew EVP, Global Operations	Officer	1 190 Value: $60.0K
Feb 14, 2026 Buy	Common Stock M-Exempt	Woodworth Emily SVP, Global Controller And Cao	Officer	661 Value: $33.4K
Feb 14, 2026 Sell	Common Stock F-InKind	Woodworth Emily SVP, Global Controller And Cao	Officer	296 Value: $22.1K
Feb 14, 2026 Buy	Restricted Stock Units M-Exempt	Woodworth Emily SVP, Global Controller And Cao	Officer	661 Value: $33.4K
Feb 13, 2026 Sell	Common Stock F-InKind	Monson Jonathan EVP And CFO	C-Suite Officer	788 Value: $58.9K
Feb 13, 2026 Buy	Common Stock M-Exempt	Monson Jonathan EVP And CFO	C-Suite Officer	1 766 Value: $132.0K
Feb 13, 2026 Buy	Restricted Stock Units M-Exempt	Woodworth Emily SVP, Global Controller And Cao	Officer	1 413 Value: $105.6K
Feb 13, 2026 Buy	Common Stock A-Award	Mahoney Michael F Chairman, President & CEO	CEO / President	132 190 Value: $9.88M
Feb 13, 2026 Buy	Restricted Stock Units M-Exempt	Mahoney Michael F Chairman, President & CEO	CEO / President	8 832 Value: $660.0K
Feb 13, 2026 Buy	Common Stock M-Exempt	Fitzgerald Joseph Michael EVP & Group Pres, Cardiology	Officer	2 797 Value: $209.0K
Feb 13, 2026 Buy	Common Stock M-Exempt	Mahoney Michael F Chairman, President & CEO	CEO / President	8 832 Value: $660.0K
Feb 13, 2026 Buy	Common Stock A-Award	Mahoney Michael F Chairman, President & CEO	CEO / President	132 190 Value: $9.88M
Feb 13, 2026 Buy	Common Stock M-Exempt	O'sullivan Miriam SVP, Chief Hr Officer	Officer	588 Value: $43.9K
Feb 13, 2026 Sell	Common Stock F-InKind	O'sullivan Miriam SVP, Chief Hr Officer	Officer	200 Value: $14.9K
Feb 13, 2026 Buy	Restricted Stock Units M-Exempt	O'sullivan Miriam SVP, Chief Hr Officer	Officer	588 Value: $43.9K
Feb 13, 2026 Buy	Restricted Stock Units M-Exempt	Monson Jonathan EVP And CFO	C-Suite Officer	1 766 Value: $132.0K
Feb 13, 2026 Sell	Common Stock F-InKind	Mahoney Michael F Chairman, President & CEO	CEO / President	132 099 Value: $9.87M
Feb 13, 2026 Sell	Common Stock F-InKind	Fitzgerald Joseph Michael EVP & Group Pres, Cardiology	Officer	33 104 Value: $2.47M
Feb 13, 2026 Buy	Common Stock A-Award	Fitzgerald Joseph Michael EVP & Group Pres, Cardiology	Officer	34 898 Value: $2.61M
Feb 13, 2026 Buy	Common Stock M-Exempt	O'connor Padraig Andrew EVP, Global Operations	Officer	500 Value: $37.4K
Feb 13, 2026 Sell	Common Stock F-InKind	O'connor Padraig Andrew EVP, Global Operations	Officer	199 Value: $14.9K
Feb 13, 2026 Buy	Restricted Stock Units M-Exempt	O'connor Padraig Andrew EVP, Global Operations	Officer	500 Value: $37.4K
Feb 13, 2026 Buy	Common Stock M-Exempt	Woodworth Emily SVP, Global Controller And Cao	Officer	1 413 Value: $105.6K
Feb 13, 2026 Sell	Common Stock F-InKind	Woodworth Emily SVP, Global Controller And Cao	Officer	690 Value: $51.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BOSTON SCIENTIFIC CORPORATION

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization th...

Read Full Profile Here